Bristol-Myers Squibb Company (BMY)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 12:59PM EDT. Market open.
| Previous Close | 74.56 |
| Open | 74.77 |
| Bid | 73.93 x 800 |
| Ask | 73.95 x 1400 |
| Day's Range | 73.81 - 74.95 |
| 52 Week Range | 53.22 - 80.59 |
| Volume | |
| Avg. Volume | 11,349,591 |
| Market Cap | 157.646B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | 24.53 |
| EPS (TTM) | 3.01 |
| Earnings Date | Oct 26, 2022 |
| Forward Dividend & Yield | 2.16 (2.90%) |
| Ex-Dividend Date | Jun 30, 2022 |
| 1y Target Est | 81.38 |
- Motley Fool
3 High-Yielding Dividend Stocks That Are Ideal for Retirees
Bristol Myers is a top drugmaker that investors can count on for long-term growth and dividend income. In its most recent quarter, for the period ended June 30, the company reported revenue of $11.9 billion that rose 2% year over year. The company's continued innovation makes it a promising investment.
- Business Wire
Bristol Myers Squibb Completes Acquisition of Turning Point Therapeutics, Expanding Precision Oncology Portfolio
NEW YORK, August 17, 2022--Bristol Myers Squibb Completes Acquisition of Turning Point Therapeutics, Expanding Precision Oncology Portfolio
- Business Wire
Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics
NEW YORK & SAN DIEGO, August 16, 2022--Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from SEE RELEASE FOR FULL TITLE
© 2022 Yahoo. All rights reserved.
